234.19
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché STE Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$236.60
Aprire:
$237.27
Volume 24 ore:
185.43K
Relative Volume:
0.23
Capitalizzazione di mercato:
$22.83B
Reddito:
$5.94B
Utile/perdita netta:
$785.30M
Rapporto P/E:
29.52
EPS:
7.9331
Flusso di cassa netto:
$972.40M
1 W Prestazione:
+1.13%
1M Prestazione:
+7.99%
6M Prestazione:
-5.62%
1 anno Prestazione:
-5.13%
Steris Plc Stock (STE) Company Profile
Nome
Steris Plc
Settore
Industria
Telefono
35312322000
Indirizzo
70 SIR JOHN ROGERSON'S QUAY, DUBLIN
Compare STE vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
STE
Steris Plc
|
234.19 | 23.07B | 5.94B | 785.30M | 972.40M | 7.9331 |
|
ABT
Abbott Laboratories
|
110.57 | 191.92B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
SYK
Stryker Corp
|
339.81 | 133.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
90.60 | 116.18B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
BSX
Boston Scientific Corp
|
51.37 | 74.52B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
92.34 | 53.63B | 6.30B | 1.07B | 1.09B | 1.8406 |
Steris Plc Stock (STE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2025-05-29 | Iniziato | Jefferies | Hold |
| 2024-10-24 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2024-02-06 | Ripresa | KeyBanc Capital Markets | Overweight |
| 2023-05-30 | Iniziato | Morgan Stanley | Equal-Weight |
| 2023-04-14 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-09-23 | Downgrade | Needham | Buy → Hold |
| 2022-07-14 | Iniziato | Piper Sandler | Overweight |
| 2022-04-07 | Iniziato | Wolfe Research | Outperform |
| 2021-05-26 | Aggiornamento | Needham | Hold → Buy |
| 2021-02-04 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-09-02 | Iniziato | Robert W. Baird | Outperform |
| 2020-06-09 | Iniziato | Needham | Hold |
| 2019-07-10 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2018-01-03 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2017-06-05 | Downgrade | Wellington Shields | Gradually Accumulate → Hold |
| 2017-05-03 | Aggiornamento | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2016-11-30 | Iniziato | Goldman | Neutral |
| 2016-06-03 | Aggiornamento | Northcoast | Neutral → Buy |
| 2015-06-12 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2013-05-07 | Downgrade | Griffin Securities | Buy → Hold |
| 2013-02-08 | Reiterato | Griffin Securities | Buy |
| 2012-08-03 | Aggiornamento | JMP Securities | Mkt Perform → Mkt Outperform |
| 2012-02-08 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2011-11-03 | Reiterato | JMP Securities | Mkt Outperform |
| 2011-02-09 | Reiterato | JMP Securities | Mkt Outperform |
| 2010-12-21 | Reiterato | JMP Securities | Mkt Outperform |
| 2010-09-17 | Iniziato | JMP Securities | Mkt Outperform |
| 2010-04-07 | Reiterato | CL King | Strong Buy |
| 2010-03-26 | Iniziato | CL King | Strong Buy |
| 2010-03-03 | Iniziato | Brean Murray | Hold |
Mostra tutto
Steris Plc Borsa (STE) Ultime notizie
STERIS (NYSE:STE) Director Sells $956,795.24 in Stock - MarketBeat
Steris Insider Sold Shares Worth $956,795, According to a Recent SEC Filing - marketscreener.com
STERIS (STE) director Louis Shapiro granted 1,025 fully vested stock units - Stock Titan
STERIS plc (STE) director Nirav Shah receives new stock options and RSUs - Stock Titan
STERIS plc (STE) director awarded stock options and Career RSUs - Stock Titan
STERIS plc (STE) director Holland receives 1,025 Career Restricted Stock Units - Stock Titan
STERIS (STE) director Cynthia Feldmann receives options and RSU awards - Stock Titan
STERIS plc (STE) director Pierre Boulud receives 1,025 Career RSUs - Stock Titan
STERIS plc SEC Filing (Aug 12, 2026) - Stock Titan
Jefferies Adjusts Price Target on STERIS to $232 From $225, Maintains Hold Rating - marketscreener.com
Assenagon Asset Management S.A. Has $16.10 Million Stake in STERIS plc $STE - MarketBeat
STERIS plc (STE) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
STERIS investing $600 million to build formulated chemistries manufacturing and distribution Center of Excellence - Today's Medical Developments
STERIS plc (Ireland) (STE) Stock Forecasts - Yahoo! Finance Canada
STERIS Q1 Earnings Call Highlights - MarketBeat
STERIS (NYSE:STE) Raised to Buy at Wall Street Zen - MarketBeat
Steris plc (0XI8) Q3 2026 Earnings ReportResults, Call & Slides - TipRanks
Did STERIS’ (STE) Record Chemistries Bet and Dividend Hike Just Recast Its Earnings Narrative? - simplywall.st
STERIS (STE) Stock Faces Valuation Scrutiny After Margin Gains And Higher Capex - Sahm
UBS Maintains Steris PLC(STE.US) With Buy Rating, Cuts Target Price to $270 - Moomoo
STERIS plc (Ireland) (STE) Stock forecasts - Yahoo Finance UK
STERIS plc (STE) Announces Shareholder Voting Results and Board Reduction at 2026 Annual General Meeting - GuruFocus
UBS Group Issues Pessimistic Forecast for STERIS (NYSE:STE) Stock Price - MarketBeat
Steris PLC stock outperforms competitors on strong trading day - MarketWatch
STERIS plc 2026: Revenue $1.49B, EPS $2.04— 10-Q Summary - TradingView
STERIS plc (NYSE: STE) lifts Q1 2027 revenue to $1.49B, EPS hits $2.04 - Stock Titan
STE Reiterated by Piper Sandler -- Price Target Raised to $275 - GuruFocus
STERIS (NYSE:STE) Given Overweight Rating at Piper Sandler - MarketBeat
Narrow-Moat Steris' Recurring Revenue and Margin Improvement Create Opportunistic Outlook - Morningstar
UBS Adjusts Price Target on STERIS to $270 From $275, Maintains Buy Rating - marketscreener.com
STERIS plc (STE) Stock News Today - TradingKey
Steris Earnings: Healthy Fundamentals Allow for Accelerated Repurchases and More Investment - Morningstar
Steris PLC (STE) (Q1 2027) Earnings Call Highlights: Strong Reve - GuruFocus
STERIS plc (Ireland) Stock 12‑Month Price Target Cut to $260.67, Implies 12% Upside - TradingView
Needham Maintains Steris PLC(STE.US) With Hold Rating - Moomoo
Earnings call transcript: STERIS beats Q1 2026 EPS, shares fall on spending plans - Investing.com
Steris Posts Solid Q1 Results Amid Restructuring Plans - The Globe and Mail
NCRR Injecting $600K Into STERIS Facility - Railway Age
Steris plc Appoints Pierre Boulud to the Audit Committee and the Compliance and Technology Committee - marketscreener.com
Medical equipment company to close St. Louis-area plant as it moves work to new $600M facility in NC - The Business Journals
[STE Q1 2027 Earnings Call] STERIS Plans $600M Chemical Manufacturing Hub, Q1 EPS Jumps 11% to $2.59 - finance.biggo.com
Q1 2027 STERIS plc Earnings Call Transcript - GuruFocus
Cetera Investment Advisers Sells 17,585 Shares of STERIS plc $STE - MarketBeat
Should STERIS' (STE) Record Chemistries Investment and Dividend Hike Require Action From Investors? - finance.yahoo.com
STERIS Q1 Adjusted Earnings, Revenue Rise; Reaffirms Guidance - Moomoo
Steris Expects to Incur Total Pre-Tax Restructuring Charges of About $55M-$70M - Moomoo
STERIS plc reports results for the quarter ended June 30Earnings Summary - TradingView
Aug 05 (Reuters)Steris Q1 EPS USD 2.04. Q - Moomoo
Here's What Key Metrics Tell Us About Steris (STE) Q1 Earnings - Yahoo Finance
STERIS (NYSE:STE) Posts Q2 CY2026 Sales In Line With Estimates - Yahoo Finance
Steris (STE) Q1 Earnings Surpass Estimates - Yahoo Finance
Steris Plc Azioni (STE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):